Fundraising FoxAlphaeon
Irvine, US · Founded 2012 · California corporation · 1 known investors
Find your way into Alphaeon
Sign up to see every warm intro you have to Alphaeon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alphaeon team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Alphaeon was founded in 2012 by Robert E. Grant.
RE
Robert E. GrantFounder
JG
Jeevan GoreExecutive
RR
Robert RhatiganExecutive
CK
Craig KussmanExecutive
Board
WL
William LinkChairman of the Board
RH
Robert HaymanBoard director
JT
RL
Richard LindstromBoard director
HS
Hans S. KeirsteadBoard director
PM
Patrick MaxwellBoard director
VM
Vikram MalikBoard director
VT
Valerie TaupinBoard director
Investors · 1
Longitude CapitalreportedMenlo Park · $10M – $30Mvia Bakker · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$197.1M disclosed across 6 rounds · 2015–2022
▶$24.5MraisedAug 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$24.5MraisedAug 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chad OhExecutive Officer
- Robert GrantDirector
- Chris CarrExecutive Officer
- Vikram MalikDirector
- Simone BlankDirector
- Alex WilsonExecutive Officer
- Marc ForthExecutive Officer
- Richard TaketaDirector
- Darren O'BrienDirector
- Jost FischerDirector
- Offering amount
- $25M
- Amount sold
- $24.5M
- First sale
- Dec 2021
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$30MraisedAug 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$30MraisedAug 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jost FischerDirector
- Robert GrantDirector
- Darren O'BrienDirector
- Simone BlankDirector
- Alex WilsonExecutive Officer
- Marc ForthExecutive Officer
- Vikram MalikDirector
- Richard TaketaDirector
- Chris CarrExecutive Officer
- Chad OhExecutive Officer
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jul 2022
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$30MraisedMay 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$30MraisedMay 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert GrantDirector
- Richard TaketaDirector
- Jost FischerDirector
- Marc ForthExecutive Officer
- Vikram MalikDirector
- Simone BlankDirector
- Scott AkamineExecutive Officer
- Darren O'BrienDirector
- Chris CarrExecutive Officer
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedAug 2016 · 5 investors · Other Health CareRule 506(b)
▶$5.5MraisedAug 2016 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Craig KussmanExecutive Officer
- William LinkExecutive Officer, Director
- Bosun HauDirector
- Robert E. GrantDirector
- Hans S. KeirsteadDirector
- Patrick MaxwellDirector
- Richard LindstromDirector
- Robert HaymanDirector
- Robert RhatiganExecutive Officer
- Dennis WolfDirector
- Vikram MalikDirector
- Juliet Tammenoms BakkerDirector
- Bill RichardsonDirector
- Christopher CoxDirector
- Simone BlankDirector
- Offering amount
- $55M
- Amount sold
- $5.5M
- Proceeds to insiders
- $1M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$80.1MraisedNov 2015 · 28 investors · Other Health CareRule 506(b)
▶$80.1MraisedNov 2015 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard LindstromDirector
- William LinkExecutive Officer, Director
- Patrick MaxwellDirector
- Juliet Tammenoms BakkerDirector
- Dennis WolfDirector
- Hans S. KeirsteadDirector
- Vikram MalikDirector
- Robert RhatiganExecutive Officer
- Craig KussmanExecutive Officer
- James Xiaodong LiuDirector
- Christopher CoxDirector
- Valerie TaupinDirector
- Robert HaymanDirector
- Robert E. GrantExecutive Officer, Director
- Offering amount
- $150M
- Amount sold
- $80.1M
- Sales commissions
- $2.8M
- Placement agents
- Piper Jaffray & Co.
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$27MraisedJan 2015 · 5 investors · Other Health CareRule 506(b)
▶$27MraisedJan 2015 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard LindstromDirector
- Robert E. GrantExecutive Officer, Director
- Jeevan GoreExecutive Officer
- Hans S. KeirsteadDirector
- Patrick MaxwellDirector
- William LinkExecutive Officer, Director
- Robert RhatiganExecutive Officer
- Craig KussmanExecutive Officer
- Vikram MalikDirector
- Robert HaymanDirector
- Juliet Tammenoms BakkerDirector
- Valerie TaupinDirector
- Offering amount
- $40.5M
- Amount sold
- $27M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Alphaeon?
- Alphaeon was founded by Robert E. Grant in 2012.
- Who are Alphaeon's investors?
- Alphaeon's investors include Longitude Capital.
- How much funding has Alphaeon raised?
- Alphaeon has disclosed $197.1M raised across 6 rounds.
- Where is Alphaeon headquartered?
- Alphaeon is headquartered in Irvine, US.